Business Context and Reporting Period
Company: ACV Auctions Inc. (ACVA)
Filing Type: Form 8-K (Current Report)
Date of Report: September 10, 2026
Event: Entry into a Material Definitive Agreement (Agreement and Plan of Merger) with Copart, Inc. ("Parent") and Apple Merger Sub, Inc. ("Merger Sub").
Key Financial Metrics and Transaction Terms
This filing details a proposed acquisition rather than standard operating financial results. Key transaction metrics include:
- Offer Price: $10.50 per share in cash, net to the seller.
- Transaction Structure: Cash tender offer followed by a merger under Section 251(h) of the Delaware General Corporation Law.
- Minimum Condition: Tender of shares representing at least one share more than 50% of outstanding ACV Stock.
- Termination Fees:
- ACV to pay Parent: $57,700,000 (if ACV terminates to accept a Superior Proposal).
- Parent to pay ACV: $115,300,000 (if Parent terminates due to HSR/Competition Law injunctions or failure to satisfy conditions).
- Support Agreement: Certain stockholders owning approximately 4.1% of outstanding stock have agreed to tender shares and vote in favor of the merger.
Note: The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures for ACV Auctions Inc.
Material Changes and Operational Impact
The primary material change is the initiation of a change of control transaction. Upon consummation:
- ACV will become a wholly-owned subsidiary of Copart, Inc.
- ACV's common stock will cease to be publicly traded on the New York Stock Exchange.
- Equity Awards:
- Vested Options: In-the-money options will be cashed out; out-of-the-money options will be canceled for no consideration.
- Unvested Options/RSUs: Will generally convert into Copart equity awards based on an Exchange Ratio.
- Performance Stock Units: Will convert based on the greater of target or actual performance.
- ESPP: The Employee Stock Purchase Plan will terminate on the earlier of the first purchase date following the agreement or the tenth trading day prior to the Effective Time.
Guidance, Outlook, and Risks
Outlook and Management Commentary: The filing includes a joint press release and investor presentation (Exhibits 99.1 and 99.2) discussing anticipated benefits, cost and revenue synergies, and the expected impact on Copart's revenue growth and earnings per share. Management has agreed to operate the business in the ordinary course until closing.
Risks and Contingencies: The transaction is subject to customary closing conditions, including:
- Receipt of required regulatory approvals (Hart-Scott-Rodino Antitrust Improvements Act).
- Absence of injunctions prohibiting the merger.
- Stockholder tendering sufficient shares to meet the Minimum Condition.
- Failure to realize anticipated synergies or integration challenges.
- Potential stockholder litigation.
Forward-Looking Statements: The document contains forward-looking statements regarding the timing of the tender offer, the success of the merger, and post-closing operations, which are subject to significant risks and uncertainties.
Investor Verification Checklist
- Verify the final tender offer materials (Schedule TO) and ACV's recommendation statement (Schedule 14D-9) once filed with the SEC.
- Confirm the exact Exchange Ratio for converting unvested equity awards once disclosed in the definitive merger agreement.
- Monitor regulatory approval status, specifically regarding antitrust reviews under the HSR Act.
- Review the full text of the Merger Agreement (Exhibit 2.1) for specific representations, warranties, and covenants not detailed in this summary.
- Assess the impact of the "no-shop" provision and the specific definition of a "Superior Proposal" if a competing bid emerges.